FDA Inspection 1207147 — Catalent Maryland Inc
The FDA completed an inspection of Catalent Maryland Inc on March 10, 2023 in Harmans, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 10, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Harmans, MD (United States)